Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Fish Oil

Phase 2

GGCP-Service International West GmbH

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Intensive Care UnitRecruiting

Intensive Care UnitPhase 2

Recruiting

Timeline

Expected Milestones

Q3 2030

Phase 2Recruiting

Intensive Care Unit

NCT06279793

Clinical

Trials by Indication[1]

Intensive Care Unit1 trial

Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients: a Phase II Multicenter Trial - A Randomized, Placebo-controlled Trial -

Recruiting·GGCP-Service International West GmbH·Phase 2·NCT06279793·550 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Fish Oil. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Fish Oil. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — GCP-Service International West GmbH company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 2[1]
Company: GGCP-Service International West GmbH

Related News